PEG-MNP |
Pegylated polydopamine nanoparticles |
50 |
|
3D OA vascular imaging |
[29] |
PEG-MNP |
Linear polydopamine nanoparticles |
- |
|
OA vascular imaging |
[30] |
PEG-MNP |
Melanin nanoparticle |
7–10 |
|
Assessing tumor vasculature and response to antiangiogenic therapy |
[31] |
PEG-MNP-CA |
Pegylated polydopamine nanoparticles decorated with citraconic amide |
130 |
Tumor acidic microenvironment |
OA cancer imaging |
[32] |
64Cu-Fe-cRGDfC-PEG-MNP |
Pegylated polydopamine nanoparticles conjugated to cyclic RGD peptide and loaded with 64Cu2+ and Fe3+
|
5–10 |
αvβ3 integrins |
OA cancer imaging of integrins and multimodality imaging (OA/PET/MRI) |
[33] |
DOX-RGDC-PEG-MNP |
Pegylated polydopamine nanoparticles conjugated to cyclic RGD peptide and loaded with doxorubicin |
120 |
αvβ3 integrins |
OA cancer imaging of integrins and chemo-photothermal therapy of tumors |
[34] |
125I-Pt-cRGDyC-PEG-MNP-GNR |
Gold nanorods decorated with pegylated polydopamine nanoparticles conjugated to cyclic RGD peptide and loaded with cisplatin and 125I |
54 |
αvβ3 integrins |
OA cancer imaging of integrins, chemo-photothermal therapy of tumors and multimodality imaging (OA, SPECT) |
[35] |
ICG-Fe-PEG-MNP |
Pegylated polydopamine nanoparticles loaded with indocyanine green and Fe3+
|
146 |
|
Photothermal therapy of tumors and multimodality imaging (OA, MRI) |
[36] |
SRF-PEG-MNP |
Pegylated polydopamine nanoparticles loaded with sorafenib |
60 |
|
Imaging-guided chemotherapy |
[37] |
Gd-64Cu-PEG-MNP |
Pegylated polydopamine nanoparticles loaded with Gd3+ and 64Cu2+
|
15 |
|
Multimodality imaging (OA/MRI/PET) |
[38] |
Fe-MNP |
Polydopamine nanoparticles loaded with Fe3+
|
98 |
|
Multimodality imaging (OA/MRI) |
[39] |
MNP-CD |
Melanin-decorated carbonaceous dots |
40 |
|
Multimodality imaging (OA/OI) |
[40] |